RepliCel Life Sciences REPCF Stock
RepliCel Life Sciences Price Chart
RepliCel Life Sciences REPCF Financial and Trading Overview
RepliCel Life Sciences stock price | 0.04 USD |
Previous Close | 0.18 USD |
Open | 0.18 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.18 - 0.18 USD |
52 Week Range | 0.05 - 0.19 USD |
Volume | 136.85K USD |
Avg. Volume | 6.06K USD |
Market Cap | 11.72M USD |
Beta (5Y Monthly) | 1.06514 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
REPCF Valuation Measures
Enterprise Value | 11.63M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 33.119217 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 32.879 |
Enterprise Value/EBITDA | -7.725 |
Trading Information
RepliCel Life Sciences Stock Price History
Beta (5Y Monthly) | 1.06514 |
52-Week Change | 93.47% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.19 USD |
52 Week Low | 0.05 USD |
50-Day Moving Average | 0.12 USD |
200-Day Moving Average | 0.09 USD |
REPCF Share Statistics
Avg. Volume (3 month) | 6.06K USD |
Avg. Daily Volume (10-Days) | 18.21K USD |
Shares Outstanding | 65M |
Float | 23.06M |
Short Ratio | N/A |
% Held by Insiders | 55.22% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -259.87% |
Operating Margin (ttm) | -425.81% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -121.0040% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 353.74K USD |
Revenue Per Share (ttm) | 0.008 USD |
Quarterly Revenue Growth (yoy) | 0% |
Gross Profit (ttm) | N/A |
EBITDA | -1505525 USD |
Net Income Avi to Common (ttm) | -919267 USD |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 697.26K USD |
Total Cash Per Share (mrq) | 0.01 USD |
Total Debt (mrq) | 757.38K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.566 |
Book Value Per Share (mrq) | -0.09 |
Cash Flow Statement
Operating Cash Flow (ttm) | -2194473 USD |
Levered Free Cash Flow (ttm) | -1213566 USD |
Profile of RepliCel Life Sciences
Country | United States |
State | BC |
City | Vancouver |
Address | 570 Granville Street |
ZIP | V6C 3P1 |
Phone | 604-248-8730 |
Website | https://www.replicel.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. The company is headquartered in Vancouver, Canada.
Q&A For RepliCel Life Sciences Stock
What is a current REPCF stock price?
RepliCel Life Sciences REPCF stock price today per share is 0.04 USD.
How to purchase RepliCel Life Sciences stock?
You can buy REPCF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for RepliCel Life Sciences?
The stock symbol or ticker of RepliCel Life Sciences is REPCF.
Which industry does the RepliCel Life Sciences company belong to?
The RepliCel Life Sciences industry is Biotechnology.
How many shares does RepliCel Life Sciences have in circulation?
The max supply of RepliCel Life Sciences shares is 65.05M.
What is RepliCel Life Sciences Price to Earnings Ratio (PE Ratio)?
RepliCel Life Sciences PE Ratio is now.
What was RepliCel Life Sciences earnings per share over the trailing 12 months (TTM)?
RepliCel Life Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the RepliCel Life Sciences company belong to?
The RepliCel Life Sciences sector is Healthcare.